TBA Law Blog

Posted by: Brittany Sims on May 20, 2015

A $200 million settlement has been reached to pay out claims in the 2012 nationwide outbreak of fungal meningitis that was first detected in Nashville and was traced to an injectable steroid made by Massachusetts-based New England Compounding Center (NECC). The outbreak sickened 778 people across the country, killing 76, according to an investigation by the U.S. Food and Drug Administration. Tennessee was one of the hardest hit states with a total of 153 people sickened and 16 deaths. Dozens of civil lawsuits from across the country were consolidated into the bankruptcy filing of NECC. About 3,770 people nationwide have filed claims against the company. The Tennessean has the story.